Fractional Executive Leadership | Turnarounds | Scale-Ups | Value Creation
Transforming MedTech and Life Science assets into high-growth organizations.
SGF Executive Group steps into complex operating environments to stabilize performance, accelerate commercial growth, and build execution cultures that drive value creation.
Built for critical inflection points
When the next quartercannot be another
diagnostic exercise.
Founders, boards, and PE firms call SGF when the organization needs executive intervention, not another slide deck. The work is hands-on, cross-functional, and built around rapid control, credible communication, and measurable value creation.
01
The Stagnation Pivot
Unlock EBITDA expansion through commercial repositioning, pricing discipline, channel clarity, and leadership alignment.
02The Growth Gap
Scale the operating infrastructure needed to support customer growth, board confidence, and high-value exit readiness.
03The Leadership Void
Stabilize performance through interim leadership during sudden transitions, high-stakes turnarounds, or post-acquisition resets.
Services
Three ways SGF creates executive leverage.
Fractional & Interim CxO Leadership
On-demand C-level commercial and operating leadership for small and mid-market medical device, healthtech, and consumable companies.
90-Day Turnaround and Scaling Roadmap
Structured intervention to diagnose, stabilize, realign, and prepare the company for growth, investment, or transition.
Value Creation and Asset Commercialization
Commercial, operational, and leadership diligence to protect EBITDA, validate growth assumptions, and build credible exit paths.
Proven framework
The 90-day cycle from uncertainty to investor-ready performance.
SGF employs a structured, high-velocity framework designed to restore performance, compliance, and leadership alignment in small to mid-size medical device firms.
Proven framework
The 90-day cycle from uncertainty to investor-ready performance.
SGF employs a structured, high-velocity framework designed to restore performance, compliance, and leadership alignment in small to mid-size medical device firms.
Days 1-30Diagnose and stabilize
Rapid audit of financials, operations, QMS, and leadership. Establish a transparent communication loop with the board and investors.
Outcome: clarity, confidence, control.Add Your Heading Text Here
Days 31-60Execute and realign
Enforce operating discipline, drive CAPA and compliance closure, reset vendors, restore customer trust, and install a KPI cadence.
Outcome: operating rhythm and visibility.Add Your Heading Text Here
Days 61-90Rebuild and accelerate
Pivot from recovery to growth by clarifying strategy, aligning leadership, and preparing the organization for investment or scaling.
Outcome: investor-ready growth plan.Proven enterprise impact
Built on operator experience in regulated, high-pressure environments.
$150MRapid crisis scale
Delivered an emergency response ventilator program for the Canadian government on time and under budget during a national health crisis.
13.5%EBITDA expansion
Drove EBITDA expansion above plan in year one for a stagnant global infection control manufacturer through commercial repositioning.
$100M+Exit pathway
Operationalized and commercialized a newly acquired Class II asset from company inception to a viable PE exit valuation path.
The SGF advantage
Advisory thinking with operating accountability.
Targeted expertise
Fractional CXO leadership backed by deep MedTech experience across commercial, operations, manufacturing, and regulatory domains.
Add Your Heading Text Here
Rapid deployment
Proven turnaround frameworks and methodologies deployed quickly enough to change the trajectory of the current quarter.
Add Your Heading Text Here
Comprehensive intervention
Hands-on execution combined with executive-to-board advisory capability for high-stakes decisions and stakeholder communication.
Contact Path
Start with a rapid assessment.
Use the first conversation to pressure-test the commercial
architecture, operating bottlenecks, stakeholder risk, and the leverage
points most likely to change the next 90 days.
Contact Path
Start with a rapid assessment.
Use the first conversation to pressure-test the commercial
architecture, operating bottlenecks, stakeholder risk, and the leverage
points most likely to change the next 90 days.
We partner with MedTech executives, teams, founders and investors to shape strategy, enhance organizational effectiveness, and accelerate growth through hands-on execution.
SGF Executive Group
Canada / USA / Global
Copyright © 2026 SGF Executive Group – All Rights Reserved.